Metformin 1000 mg (ttd)

DRUG2 trials

Sponsors

GlaxoSmithKline, Oman Ministry of Health

Conditions

Dapagliflozin Adverse ReactionDiabetes Mellitus, Type 2Effect of DrugObesityWeight Loss

Phase 4

A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin

CompletedNCT00386100

GlaxoSmithKlineDiabetes Mellitus, Type 2

Start: 2006-10-31End: 2009-09-30Updated: 2016-11-23

The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes

Active, not recruitingNCT06000462

Oman Ministry of HealthDapagliflozin Adverse Reaction, Effect of Drug, Obesity +1

Start: 2024-04-22End: 2025-12-30Target: 150Updated: 2025-03-26